首页> 外国专利> Process for the production of sinus node cells ('cardiac pacemaker cells') from stem cells and process for the purification of sinus node cells generated from stem cells

Process for the production of sinus node cells ('cardiac pacemaker cells') from stem cells and process for the purification of sinus node cells generated from stem cells

机译:从干细胞生产窦房结细胞(“心脏起搏器细胞”)的方法和从干细胞产生的窦房结细胞的纯化方法

摘要

Process for the production of sinus node cells ("cardiac pacemaker cells") from stem cells, with the exception of human embryonic stem cells, in whichi. at least one sinus node cell-producing polynucleotide or at least one protein encoded by this at least one sinus node cell-producing polynucleotide is introduced into stem cells; ii the resulting stem cells in the presence of the at least one sinus node cell-producing polynucleotide or the at least one protein are differentiated into sinus node cells, the at least a polynucleotide generating sinus node cells comprises a nucleic acid sequence which is selected from the group consisting ofa) nucleic acid sequence selected from the group consisting of Gm20685, Gm21989, 1700027A07Rik, 4930448N21 Rik, Acadvl, Actn2, Adm, Adprhl1k, Ak1, Afap1l , Amfr, Angptl2, Ank, Ankrd1, Ap1m1, Art3, Atp2a2, Atp5a1, BC090627, Chkb, Cpt1b, C230088H06Rik, C630028M04Rik, Cap2, Casq1, Casq2, Cav3, Cdh13, Cfl2, Cn1, Cn2, Ch9 , Ctgf, D430001F17Rik, Def8, Dhrs13os, Dkk3, Dlst, Dnaja4, Dpysl2, Dusp3, Ech1, Ehd4, Eno3, Eral1, Etfd h, Fads3, Fam134b, Fam54b, Fhl1, Foxs1, Fuca2, Gal, Gbas, Gfpt2, Gja1, Gm12940, Gm13938, Gm14812, Gm15418, Gm15494, Gm2990, Got1, Gpx3, Gtf2h3, Gygox, Hadf, Herg, Hadf, Her Hspala, Hspb7, Htra1, Idh3a, Immt, Kars, Kctd20, Lbh, Ldb3, Lmod2, Lpl, Lrrc10, Mb, Meg3, Mest, Mllt11, Mllt3, Mybpc3, Mybphl, Myh6, Myl3, Mylkoz, Myom1, Myom1 Ndrg2, Ndufs1, Ndufv1, Nexn, Nppa, Nppb, Nrg1, Ogdh, Pam, Pcsk2os2, Pdlim5, Pet112l, Phyh, Pkp2, Pln, Pmpcb, Popdc2, Ppp1cb, Ppp1r14c, Ppp1r3g3, Ppp1r3 Rcan1, Rdh13, RP23-149A5.3, RP23-52N2.4, RP24-425N5.7 (AC109204.21), Ryr2, Scrn2, Sdc4, Sdha, Sdhd, Sh3kbp1, Slc16a1, Slc38a4, Slc8a1, Slco3apn, Snap , Snurf, Sorbs2, Spcs3, Sprr1a, Srl, Supt6h, Synpo2l, Tbrg4, Tecrl, Tgfb2, Tgm2, Tmem109, Tmem38a, Tmod1, Tnnt3, Tom1l1, Trdn, Trim55, Ttn, Ugp2, Uqcrcp1, Vdacirc1, Vdac17, and b) nucleic acid sequence which has at least 70% sequence identity to a nucleic acid sequence of group a c) Nucleic acid sequence which hybridizes to a nucleic acid sequence according to a) or b) under stringent conditions.
机译:由干细胞生产窦房结细胞(“心脏起搏器细胞”)的方法,其中人类胚胎干细胞除外。将至少一种产生窦房结细胞的多核苷酸或由该至少一种产生窦房结细胞的多核苷酸编码的至少一种蛋白质引入干细胞中; ii。将产生的至少一种产生窦房结细胞的多核苷酸或至少一种蛋白质存在下的干细胞分化成窦房结细胞,所述产生至少一种多核苷酸的窦房结细胞包含选自以下的核酸序列: a)选自Gm20685,Gm21989,1700027A07Rik,4930448N21 Rik,Acadvl,Actn2,Adm,Adprhl1k,Ak1,Afap11,Amfr,Angptl2,Ank,Ankrd1,Ap1m1,Art3,Atp2a ,BC090627,Chkb,Cpt1b,C230088H06Rik,C630028M04Rik,Cap2,Casq1,Casq2,Cav3,Cdh13,Cfl2,Cn1,Cn2,Ch9,Ctgf,D430001F17Rik,Def8,Dhrs13os,Dkk3,Dlsp,Dna4,E1sp3,Dna4, ,Eno3,Eral1,Etfd h,Fads3,Fam134b,Fam54b,Fhl1,Foxs1,Fuca2,Gal,Gbas,Gfpt2,Gja1,Gm12940,Gm13938,Gm14812,Gm15418,Gm15494,Gm2990,Got1,Gpx3,Gdf3,Gdf2 Herg,Hadf,她的Hspala,Hspb7,Htra1,Idh3a,Immt,Kars,Kctd20,Lbh,Ldb3,Lmod2,Lpl,Lrrc10,Mb,Meg3,M est,Mllt11,Mllt3,Mybpc3,Mybphl,Myh6,Myl3,Mylkoz,Myom1,Myom1 Ndrg2,Ndufs1,Ndufv1,Nexn,Nppa,Nppb,Nrg1,Ogdh,Pam,Pcsk2os2,Pdph5,Peln1, ,Popdc2,Ppp1cb,Ppp1r14c,Ppp1r3g3,Ppp1r3 Rcan1,Rdh13,RP23-149A5.3,RP23-52N2.4,RP24-425N5.7(AC109204.21),Ryr2,Scrn2,Sdc4,Sdha,Sdhd,Sh3kbp1, ,Slc38a4,Slc8a1,Slco3apn,Snap,Snurf,Sorbs2,Spcs3,Sprr1a,Srl,Supt6h,Synpo2l,Tbrg4,Tecrl,Tgfb2,Tgm2,Tmem109,Tmem38a,Tmod1,Tnnt3,Tm1,Tnt55,Tom1t ,Vdacirc1,Vdac17和b)与ac)组的核酸序列具有至少70%序列同一性的核酸序列。核酸序列在严格条件下与a)或b)的核酸序列杂交。

著录项

  • 公开/公告号DE102015226287B4

    专利类型

  • 公开/公告日2020-03-19

    原文格式PDF

  • 申请/专利权人 UNIVERSITÄT ROSTOCK;

    申请/专利号DE201510226287

  • 申请日2015-12-21

  • 分类号C12N5/071;C12N15/79;C12N15/12;

  • 国家 DE

  • 入库时间 2022-08-21 11:02:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号